Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space April 10, 2026
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer’s Disease 6-Month NDA Submission April 10, 2026
BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications April 10, 2026
Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants April 9, 2026